November 04, 2020 SITC 2020 – second chances for Merck & Co and Oncosec Among late-breaking abstracts whose titles have just gone live two mechanisms have a chance to redeem themselves.
November 19, 2014 Therapeutic focus – A few bright spots in a sparse mid-stage ovarian cancer pipeline
